FHLT — Future Health ESG Cashflow Statement
0.000.00%
Annual cashflow statement for Future Health ESG, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.181 | 0.06 | -0.048 |
| Deferred Taxes | |||
| Non-Cash Items | -0.004 | -2.6 | -0.771 |
| Unusual Items | |||
| Changes in Working Capital | -0.059 | 1.08 | 0.206 |
| Change in Prepaid Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Cash from Operating Activities | -0.244 | -1.26 | -0.718 |
| Other Investing Cash Flow Items | -201 | 187 | 0 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Cash from Investing Activities | -201 | 187 | 0 |
| Financing Cash Flow Items | 0.25 | 0 | — |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 203 | -187 | 0 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 1.45 | -0.609 | -0.718 |